Antimicrobial compounds and formulations

Details Antimicrobial compounds and formulations Antimicrobial compounds and formulations

2007-04-20

2011-11-01

Russel, Jeffrey E (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C422S032000, C426S335000, C426S532000, C514S002400, C514S003300, C514S003700, C514S019300, C514S021800, C530S329000, C530S330000, C530S345000

Reexamination Certificate

active

08048852

ABSTRACT:
The invention relates to the use of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto at least two bulky and lipophilic groups and having at least one more cationic than anionic moiety, in the manufacture of a medicament for destabilizing microbial cell membranes and the use as a membrane acting antimicrobial agent of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto a super bulky and lipophilic group comprising at least 9 non-hydrogen atoms and having at least two more cationic than anionic moieties and to methods of treatment involving such molecules, in particular peptides including peptide derivatives, and peptidomimetics.

REFERENCES:
patent: 5428016 (1995-06-01), Tomita et al.
patent: 5646301 (1997-07-01), Deghenghi
patent: 5885782 (1999-03-01), Edwards
patent: 6143795 (2000-11-01), Moschner et al.
patent: 7232803 (2007-06-01), Svendsen et al.
patent: 2003/0059827 (2003-03-01), Gonzalez
patent: 2003/0113768 (2003-06-01), Zweig
patent: 97/31019 (1997-08-01), None
patent: 97/40070 (1997-10-01), None
patent: 97/44481 (1997-11-01), None
patent: 9857174 (1998-12-01), None
patent: 99/59616 (1999-11-01), None
patent: 00/12541 (2000-03-01), None
patent: 00/12542 (2000-03-01), None
patent: 01/19852 (2001-03-01), None
Boger, Dale L., et al., “Vancomycin CD and DE Macrocyclization and Atropisomerism Studies,” J. Org. Chem., 1999, pp. 70-80, vol. 64. American Chemical Society.
Hagen, Erik A., et al., “Syntheses of Analogs of D-Ala-D-Ala as Potential Inhibitors of Bacterial Cell Wall Biosynthesis,” Acta Chem. Scad. B, 1984, pp. 5-14, vol. 38, No. 1.
Hammam, A.S., et al., “Synthesis & Biological Activities of Some New Peptide Substituted Carbazoloquinones,” Indian J. Chem., Apr. 1982, pp. 348-351, vol. 21B.
Oh, Jong Eun et al., “Synthesis of Novel Unnatural Amino Acid as a Building Block and Its Incorporation into an Antimicrobial Peptide,” Bioorganic & Medicinal Chemistry, 1999, pp. 2985-2990, vol. 7, No. 12. Elsevier Science Ltd.
Puyal, Christophe et al., “Design of a short membrane-destabilizing peptide covalently bound to liposomes,” Biochimica et Biophysica Acta, 1994, pp. 259-266, vol. 1195, No. 2. Elsevier Science Ltd.
Renau, Thomas E., et al., “Inhibitors of Efflux Pumps inPseudomonas aeruginosaPotentiate the Activity of the Fluoroquinolone Antibacterial Levofloxacin,” J. Med. Chem., 42: 4928-4931 (1999).
Spatola, Arno F., et al., “Can machine learning and combinatorial chemistry coexist? An antimicrobial peptide case study,” Peptides for the New Millennium, Proceedings of the American Peptide Symposium, 16th, Minneapolis, MN, Jun. 26-Jul. 1, 1999, pp. 738-739 (1999).
Molinero, J., et al., “Synthesis and properties of lipopeptidic surfactants,” Peptides, 1990: 436-437 (1990).
Nedev, H.N., et al., “Synthesis of L-Lysine-Containing Peptides With Antibacterial Activity,” Doklady Bolgarskol Akademii Nauk, 42: 31-34 (1989).

Affiliated with

Also associated with

Rating

Antimicrobial compounds and formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antimicrobial compounds and formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimicrobial compounds and formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4309754